177 related articles for article (PubMed ID: 17397133)
21. Adzuki bean: a new resource of biocatalyst for asymmetric reduction of aromatic ketones with high stereoselectivity and substrate tolerance.
Xie Y; Xu JH; Lu WY; Lin GQ
Bioresour Technol; 2009 May; 100(9):2463-8. PubMed ID: 19153040
[TBL] [Abstract][Full Text] [Related]
22. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
Zheng ZY; Lin VC
Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
[TBL] [Abstract][Full Text] [Related]
23. Activity of taspine isolated from Radix et Rhizoma Leonticis against estrogen-receptor-positive breast cancer.
Zhan Y; Zhang Y; Chen Y; Wang N; Zheng L; He L
Fitoterapia; 2011 Sep; 82(6):896-902. PubMed ID: 21605638
[TBL] [Abstract][Full Text] [Related]
24. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
Ju YH; Doerge DR; Helferich WG
Food Chem Toxicol; 2008 Jan; 46(1):310-20. PubMed ID: 17919800
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-like effects of ultraviolet screen 3-(4-methylbenzylidene)-camphor (Eusolex 6300) on cell proliferation and gene induction in mammalian and amphibian cells.
Klann A; Levy G; Lutz I; Müller C; Kloas W; Hildebrandt JP
Environ Res; 2005 Mar; 97(3):274-81. PubMed ID: 15589235
[TBL] [Abstract][Full Text] [Related]
26. Estrogenic activity of the dichloromethane extract from Pueraria mirifica.
Sookvanichsilp N; Soonthornchareonnon N; Boonleang C
Fitoterapia; 2008 Dec; 79(7-8):509-14. PubMed ID: 18621111
[TBL] [Abstract][Full Text] [Related]
27. Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR).
Hochmann J
Neoplasma; 2007; 54(4):290-6. PubMed ID: 17822318
[TBL] [Abstract][Full Text] [Related]
28. Estrogenic activity of isoflavonoids from Onobrychis ebenoides.
Halabalaki M; Alexi X; Aligiannis N; Lambrinidis G; Pratsinis H; Florentin I; Mitakou S; Mikros E; Skaltsounis AL; Alexis MN
Planta Med; 2006 May; 72(6):488-93. PubMed ID: 16773531
[TBL] [Abstract][Full Text] [Related]
29. Estrogenic activity of griffonianone C, an isoflavone from the root bark of Millettia griffoniana: regulation of the expression of estrogen responsive genes in uterus and liver of ovariectomized rats.
Wanda GJ; Starcke S; Zierau O; Njamen D; Richter T; Vollmer G
Planta Med; 2007 Jun; 73(6):512-8. PubMed ID: 17486534
[TBL] [Abstract][Full Text] [Related]
30. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
31. Phenolic esters from the rhizomes of Cimicifuga racemosa do not cause proliferation effects in MCF-7 cells.
Stromeier S; Petereit F; Nahrstedt A
Planta Med; 2005 Jun; 71(6):495-500. PubMed ID: 15971118
[TBL] [Abstract][Full Text] [Related]
32. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
33. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
[TBL] [Abstract][Full Text] [Related]
34. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
35. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
Stute P; Götte M; Kiesel L
Breast Cancer Res Treat; 2008 Apr; 108(3):363-74. PubMed ID: 17546497
[TBL] [Abstract][Full Text] [Related]
36. Estrogenic activity of a polyphenolic extract of the leaves of Epimedium brevicornum.
De Naeyer A; Pocock V; Milligan S; De Keukeleire D
Fitoterapia; 2005 Jan; 76(1):35-40. PubMed ID: 15664460
[TBL] [Abstract][Full Text] [Related]
37. [BRCA1 regulates progesterone receptors A and B protein expressions in breast cancer cells in vitro].
Guo YX; Zeng WS; Liu YW; Li YS; Lin J; Xiong JB; Luo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1157-60. PubMed ID: 18676251
[TBL] [Abstract][Full Text] [Related]
38. Global gene expression profiles induced by phytoestrogens in human breast cancer cells.
Dip R; Lenz S; Antignac JP; Le Bizec B; Gmuender H; Naegeli H
Endocr Relat Cancer; 2008 Mar; 15(1):161-73. PubMed ID: 18310284
[TBL] [Abstract][Full Text] [Related]
39. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
[TBL] [Abstract][Full Text] [Related]
40. Estradiol regulates alternative splicing of estrogen receptor-alpha mRNA in differentiated NG108-15 neuronal cells.
Aizawa S; Yamamuro Y
Life Sci; 2008 Mar; 82(13-14):692-8. PubMed ID: 18258268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
